Cargando…

Underrecognition of Nonalcoholic Fatty Liver Disease in Poorly Controlled Diabetes: A Call to Action in Diabetes Care

Individuals with type 2 diabetes (T2DM) are at high risk for nonalcoholic fatty liver disease (NAFLD), and evidence suggests that poor glycemic control is linked to heightened risk of progressive NAFLD. We conducted an observational study based on data from a telehealth trial conducted in 2018-2020....

Descripción completa

Detalles Bibliográficos
Autores principales:	Alexopoulos, Anastasia-Stefania, Duffy, Ryan, Kobe, Elizabeth A, German, Jashalynn, Moylan, Cynthia A, Soliman, Diana, Jeffreys, Amy S, Coffman, Cynthia J, Crowley, Matthew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570418/ https://www.ncbi.nlm.nih.gov/pubmed/34755002 http://dx.doi.org/10.1210/jendso/bvab155

Ejemplares similares

Prescribing of evidence-based diabetes pharmacotherapy in patients with metabolic dysfunction-associated steatohepatitis
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2023)

Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease
por: Alexopoulos, Anastasia‐Stefania, et al.
Publicado: (2021)

Underrecognition of Dengue during 2013 Epidemic in Luanda, Angola
por: Sharp, Tyler M., et al.
Publicado: (2015)

44499 Heterogeneity of treatment effect among patients with type 2 diabetes and body mass index >=27kg/m^2 in the Jump Start Study
por: Kobe, Elizabeth A., et al.
Publicado: (2021)

Metronidazole-Induced Pancreatitis: Is There Underrecognition? A Case Report and Systematic Review of the Literature
por: Youssef, Ibrahim, et al.
Publicado: (2019)

Underrecognition and undertreatment of thirst among hospitalized patients with restricted oral feeding and drinking
por: Ho, Vanda, et al.
Publicado: (2021)

4063 Glycemic control in a weight management-focused group medical visits (WM/GMV) intervention: examining the moderating effects of body mass index (BMI)
por: Kobe, Elizabeth, et al.
Publicado: (2020)

Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023)

Serum Bile Acid, Vitamin E, and Serotonin Metabolites Are Associated With Future Liver‐Related Events in Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2021)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Diabetes Medication Changes in Older Adults With Type 2 Diabetes: Insights Into Physician Factors and Questions Ahead
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2023)

Underrecognition and un-dertreatment of stress-related psychiatric disorders in physicians: Determinants, challenges, and the impact of the COVID-19 pandemic
por: Huang, Charles Lung-Cheng
Publicado: (2023)

ODP176 Delivery of Type 2 Diabetes Care Using Telemedicine: Provider Experiences and Perspectives
por: German, Jashalynn, et al.
Publicado: (2022)

Serum Interleukin‐8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Glass, Oliver, et al.
Publicado: (2018)

Adherence to Low-Carbohydrate Diets in Patients with Diabetes: A Narrative Review
por: Kumar, Nitya Kalyani, et al.
Publicado: (2022)

Impact of Baseline Insulin Regimen on Glycemic Response to a Group Medical Clinic Intervention
por: Crowley, Matthew J., et al.
Publicado: (2013)

The Association between Nonalcoholic Fatty Pancreas Disease and Diabetes
por: Ou, Horng-Yih, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease and Diabetes: An Epidemiological Perspective
por: Rhee, Eun-Jung
Publicado: (2019)

Nonalcoholic Fatty Liver Disease in Diabetics: The Role of Hepatologist
por: Khandelwal, Reshu, et al.
Publicado: (2022)

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease before Kidney Transplantation Correlates with New Onset Diabetes and Poor Metabolic Outcomes
por: Grupper, Ayelet, et al.
Publicado: (2022)

Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study
por: Alexopoulos, Anastasia-Stefania, et al.
Publicado: (2019)

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries
por: Fudim, Marat, et al.
Publicado: (2021)

Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease
por: Patel, Preya J., et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Dharmalingam, Mala, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
por: Fujii, Hideki, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
por: Fruci, Barbara, et al.
Publicado: (2013)

Use of a Diabetes Self-Assessment Score to Predict Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Kim, Gyuri, et al.
Publicado: (2015)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease in Diabetes. Part I: Epidemiology and Diagnosis
por: Lee, Yong-ho, et al.
Publicado: (2019)

Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
por: Kim, Kyung-Soo, et al.
Publicado: (2020)

Treatment of nonalcoholic fatty liver disease with dapagliflozin in non-diabetic patients
por: Ribeiro dos Santos, Lucas, et al.
Publicado: (2020)

Diabetes drugs for nonalcoholic fatty liver disease: a systematic review
por: Blazina, Ian, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

The Coexistence of Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
por: Kosmalski, Marcin, et al.
Publicado: (2022)

Comparison of the relationships of alcoholic and nonalcoholic fatty liver with hypertension, diabetes mellitus, and dyslipidemia
por: Toshikuni, Nobuyuki, et al.
Publicado: (2013)

Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk
por: Du, Tingting, et al.
Publicado: (2015)

Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data
por: Mavrogiannaki, A. N., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_i5coh24etipca9manl0kiavjjj